Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 142.94B | 145.59B | 153.22B | 150.02B | 133.89B | 154.31B |
Gross Profit | 28.03B | 28.58B | 34.38B | 34.02B | 30.68B | 25.59B |
EBITDA | 19.55B | 21.50B | 27.44B | 27.25B | 23.22B | 15.39B |
Net Income | 8.91B | 10.21B | 14.26B | 14.50B | 11.05B | 3.63B |
Balance Sheet | ||||||
Total Assets | 261.26B | 265.01B | 263.02B | 260.01B | 259.83B | 285.74B |
Cash, Cash Equivalents and Short-Term Investments | 25.12B | 21.74B | 18.99B | 24.36B | 29.86B | 28.45B |
Total Debt | 86.79B | 93.04B | 87.21B | 84.41B | 93.85B | 114.76B |
Total Liabilities | 165.93B | 171.38B | 170.21B | 173.47B | 186.66B | 223.49B |
Stockholders Equity | 94.31B | 92.63B | 91.77B | 85.42B | 71.95B | 60.69B |
Cash Flow | ||||||
Free Cash Flow | 10.44B | 9.07B | 6.26B | 9.99B | 17.23B | 13.77B |
Operating Cash Flow | 19.14B | 17.73B | 14.47B | 16.89B | 24.55B | 22.33B |
Investing Cash Flow | -11.21B | -8.75B | -7.32B | -3.45B | -6.23B | -6.42B |
Financing Cash Flow | -13.38B | -10.75B | -8.39B | -19.03B | -19.06B | -10.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $46.85B | 9.44 | 11.47% | 5.09% | 3.03% | 28.54% | |
76 Outperform | $59.78B | 6.48 | 9.32% | 7.69% | -6.60% | -30.08% | |
73 Outperform | $51.10B | 7.66 | 8.88% | 1.12% | 7.76% | -14.17% | |
72 Outperform | $48.56B | 8.73 | 6.54% | 3.58% | 0.83% | -26.70% | |
71 Outperform | $996.70B | 172.41 | 9.16% | ― | 1.03% | -53.71% | |
70 Outperform | $222.05B | 7.22 | 13.36% | 3.62% | 1.06% | -7.05% | |
63 Neutral | $16.85B | 11.25 | -7.01% | 2.93% | 1.72% | -24.85% |